Valuation dashboard for Bionano Genomics, Inc. (BNGO) with P/E N/A, P/B 0.54, EV/EBITDA -0.75 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Bionano Genomics, Inc. focuses on providing advanced solutions for analyzing genomes. The company's flagship offering is Saphyr, a complete system that processes samples to results, enabling the analysis of structural variations in the genome using optical genome mapping. This technology is vital for deciphering genetic variations and their functional roles.
Analysis Summary
Bionano Genomics, Inc. reported revenue of $28.5M in the most recent fiscal year, growing at a 5-year CAGR of 27.4%.
Trailing-twelve-month margins: gross margin 47.5%, operating margin -106.7%, net margin -106.6%.
At the current price of $1.51, BNGO has negative trailing earnings (P/E not meaningful) and an ROE of -78.78%. Market capitalisation stands at $17M.
Balance sheet quality for BNGO: current ratio of 2.0. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.54 |
| EV / EBITDA | -0.75 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| BNGO | Bionano Genomics, Inc. | $17M | 0.54 | -78.8% | |
| 0R29.L | Intuitive Surgical, Inc. | $135.9B | 74.05 | 11.86 | 17.8% |
| ISRG | Intuitive Surgical, Inc. | $135.1B | 44.13 | 7.62 | 17.8% |
| 0R19.L | Becton, Dickinson and Company | $52.5B | 33.21 | 2.19 | 6.6% |
| BDX | Becton, Dickinson and Company | $49.0B | 54.89 | 2.05 | 3.8% |
| RMD | ResMed Inc. | $33.1B | 22.81 | 5.23 | 23.9% |
| 0KW4.L | ResMed Inc. | $31.1B | |||
| MDLN | Medline Inc. | $27.6B | 38.36 | 2.44 | 10.8% |
Price
| Price | $1.51 |
| Market Cap | $17M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -78.78% |
| Return on Invested Capital | -83.76% |
| Return on Assets | -67.58% |
| Gross Margin | 47.50% |
| Operating Margin | -106.67% |
| Net Margin | -106.58% |
Related companies: AIM · BNBX · GBS · KTTA · MYNZ · NDRA · POAI
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of BNGO: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks